Economic modeling of new stent platforms to evaluate cost effectiveness: Analysis of the TAXUS Liberté versus TAXUS express stents

Journal of Interventional Cardiology

Volumn 25, Issue 4, 2012, Pages 353-363

  Turco, Mark A ^a   Kansal, Anuraag R ^b   Stern, Sean ^b   Amorosi, Stacey L ^c   Underwood, Paul L ^c   Lissovoy, Greg De ^b   Dawkins, Keith D ^c  

^a Vascular Therapies Covidien   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; HEART DEATH; HEART INFARCTION; HIDDEN MARKOV MODEL; MEDICARE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ARTERY DISEASE; COST-BENEFIT ANALYSIS; DRUG-ELUTING STENTS; HUMANS; MARKOV CHAINS; MODELS, ECONOMIC; PACLITAXEL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84864593978     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00737.x     Document Type: Article

References (15)

1. Garg S, Serruys PW,. Coronary stents: Current status. J Am Coll Cardiol 2010; 56: S1-S42.
2. Garg S, Serruys PW,. Coronary stents: Looking forward. J Am Coll Cardiol 2010; 56: S43-S78.
3. Allocco DJ, Cannon LA, Britt A, et al,. A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program. Trials 2010; 11: 1-15.
4. Cannon LA, Kereiakes DJ, Mann T, et al,. A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: The PERSEUS Small Vessel trial. EuroIntervention 2011; 6: 920-927.
5. Turco MA, Ormiston JA, Popma JJ, et al,. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv 2008; 1: 699-709.
6. Department of Social Security. Actuarial Publications. Period Life Table. 2006.
7. Uchida T, Popma J, Stone GW, et al,. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: A critical assessment of "oculostenotic" reintervention in patients with intermediate lesions. JACC Cardiovasc Interv 2010; 3: 403-411.
8. DRG Expert. A Comprehensive Guidebook to the DRG Classification System. Ingenix, Eden Prairie, MN, 2010.
9. Physicians' Fee and Coding Guide. Duluth, GA: Mag Mutual Healthcare Solutions, 2010.
10. RED BOOK for Windows. Ann Arbor, MI: Thomson Reuters Healthcare, 2010.
11. Arai AE, Hirsch GA,. Q-wave and non-Q-wave myocardial infarctions through the eyes of cardiac magnetic resonance imaging. J Am Coll Cardiol 2004; 44: 561-563. (Pubitemid 39078179)
12. Kushner FG, Hand M, Smith SC, Jr., et al,. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-2241.
13. Ormiston JA, Turco MA, Hall JJ, et al,. Long-term benefit of the TAXUS Liberte stent in small vessels and long lesions. Circ J 2011; 75: 1120-1129.
14. Kereiakes DJ, Cannon LA, Feldman RL, et al,. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: Primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the safety and efficacy of the use of the TAXUS Element paclitaxel-eluting coronary stent system) trial. J Am Coll Cardiol 2010; 56: 264-271.
15. Stone GW, Teirstein PS, Meredith IT, et al,. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: The PLATINUM (A Prospective, Randomized, Multicenter Trial to assess an everolimus-eluting coronary stent system [PROMUS Element] for the treatment of up to two de novo coronary artery lesions) trial. J Am Coll Cardiol 2011; 57: 1700-1708.